Tetherin Restricts Herpes Simplex Virus 1 and Is Antagonized by Glycoprotein M
Author(s) -
Caroline Blondeau,
Annegret Pelchen–Matthews,
Petra Mlčochová,
Mark Marsh,
R Milne,
Greg J. Towers
Publication year - 2013
Publication title -
journal of virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.617
H-Index - 292
eISSN - 1070-6321
pISSN - 0022-538X
DOI - 10.1128/jvi.02250-13
Subject(s) - tetherin , biology , effector , virology , viral envelope , herpes simplex virus , glycoprotein , herpesvirus glycoprotein b , virus , viral entry , microbiology and biotechnology , membrane glycoproteins , antiviral protein , viral replication , genetics , gene , rna
Tetherin is a broadly active antiviral effector that works by tethering nascent enveloped virions to a host cell membrane, thus preventing their release. In this study, we demonstrate that herpes simplex virus 1 (HSV-1) is targeted by tetherin. We identify the viral envelope glycoprotein M (gM) as having moderate anti-tetherin activity. We show that gM but not gB or gD efficiently removes tetherin from the plasma membrane and can functionally substitute for the human immunodeficiency virus type 1 (HIV-1) Vpu protein, the prototypic viral tetherin antagonist, in rescuing HIV-1 release from tetherin-expressing cells. Our data emphasize that tetherin is a broadly active antiviral effector and contribute to the emerging hypothesis that viruses must suppress or evade an array of host cell countermeasures in order to establish a productive infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom